Roche to launch 40M rapid coronavirus antigen tests per month, starting in Europe

Roche plans to make a rapid antigen test for the novel coronavirus widely available in Europe later this month, while also submitting it to FDA reviewers for an emergency authorization in the U.S.

The point-of-care diagnostic aims to provide a result within 15 minutes, as a way to screen people with or without symptoms for COVID-19.